Cargando…

MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer

Prostate cancer (PC) includes several phenotypes, from indolent to highly aggressive cancer. Actual diagnostic and prognostic tools have several limitations, and there is a need for new biomarkers to stratify patients and assign them optimal therapies by taking into account potential genetic and epi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bertoli, Gloria, Cava, Claudia, Castiglioni, Isabella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813272/ https://www.ncbi.nlm.nih.gov/pubmed/27011184 http://dx.doi.org/10.3390/ijms17030421

Ejemplares similares

MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer
por: Bertoli, Gloria, et al.
Publicado: (2015)

Potential Role of miRNAs as Theranostic Biomarkers of Epilepsy
por: Cava, Claudia, et al.
Publicado: (2018)

Portrait of Tissue-Specific Coexpression Networks of Noncoding RNAs (miRNA and lncRNA) and mRNAs in Normal Tissues
por: Cava, Claudia, et al.
Publicado: (2019)

Identification of key miRNAs in prostate cancer progression based on miRNA-mRNA network construction
por: Santo, Giulia Dal, et al.
Publicado: (2022)

Circulating microRNAs as Potential Novel Diagnostic Biomarkers to Predict Drug Resistance in Temporal Lobe Epilepsy: A Pilot Study
por: De Benedittis, Selene, et al.
Publicado: (2021)

Theranostic application of miR-429 in HER2+ breast cancer
por: Cava, Claudia, et al.
Publicado: (2020)

MicroRNA-567 dysregulation contributes to carcinogenesis of breast cancer, targeting tumor cell proliferation, and migration
por: Bertoli, Gloria, et al.
Publicado: (2016)

How interacting pathways are regulated by miRNAs in breast cancer subtypes
por: Cava, Claudia, et al.
Publicado: (2016)

Integrative Analysis with Monte Carlo Cross-Validation Reveals miRNAs Regulating Pathways Cross-Talk in Aggressive Breast Cancer
por: Colaprico, Antonio, et al.
Publicado: (2015)

In Silico Approach for the Definition of radiomiRNomic Signatures for Breast Cancer Differential Diagnosis
por: Gallivanone, Francesca, et al.
Publicado: (2019)

Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potential
por: Cava, Claudia, et al.
Publicado: (2015)

In silico identification of drug target pathways in breast cancer subtypes using pathway cross-talk inhibition
por: Cava, Claudia, et al.
Publicado: (2018)

Identification of microRNA clusters cooperatively acting on epithelial to mesenchymal transition in triple negative breast cancer
por: Cantini, Laura, et al.
Publicado: (2019)

Triple negative aggressive phenotype controlled by miR-135b and miR-365: new theranostics candidates
por: Bertoli, Gloria, et al.
Publicado: (2021)

In-Silico Integration Approach to Identify a Key miRNA Regulating a Gene Network in Aggressive Prostate Cancer
por: Cava, Claudia, et al.
Publicado: (2018)

A protein interaction map identifies existing drugs targeting SARS-CoV-2
por: Cava, Claudia, et al.
Publicado: (2020)

In Silico Discovery of Candidate Drugs against Covid-19
por: Cava, Claudia, et al.
Publicado: (2020)

Potential drugs against COVID-19 revealed by gene expression profile, molecular docking and molecular dynamic simulation
por: Cava, Claudia, et al.
Publicado: (2021)

MicroRNAs: potential biomarkers for diagnosis and prognosis of different cancers
por: Sharma, Prakash Chand, et al.
Publicado: (2020)

Use of MicroRNAs as biomarkers in the early diagnosis of prostate cancer
por: Canatan, Duran, et al.
Publicado: (2022)

Integration of mRNA Expression Profile, Copy Number Alterations, and microRNA Expression Levels in Breast Cancer to Improve Grade Definition
por: Cava, Claudia, et al.
Publicado: (2014)

MicroRNAs as clinical tools for diagnosis, prognosis, and therapy in prostate cancer
por: Ghamlouche, Fatima, et al.
Publicado: (2023)

MicroRNAs as potential biomarkers for diagnosis, therapy and prognosis of gastric cancer
por: Yuan, Hai-Liang, et al.
Publicado: (2018)

MicroRNAs as Biomarkers for Early Diagnosis, Prognosis, and Therapeutic Targeting of Ovarian Cancer
por: Mirahmadi, Yegane, et al.
Publicado: (2021)

Minor Allele Frequencies and Molecular Pathways Differences for SNPs Associated with Amyotrophic Lateral Sclerosis in Subjects Participating in the UKBB and 1000 Genomes Project
por: D’Antona, Salvatore, et al.
Publicado: (2021)

A Plasma Biomarker Panel of Four MicroRNAs for the Diagnosis of Prostate Cancer
por: Matin, Farhana, et al.
Publicado: (2018)

Integration of multiple networks and pathways identifies cancer driver genes in pan-cancer analysis
por: Cava, Claudia, et al.
Publicado: (2018)

Circulating MicroRNAs as Quantitative Biomarkers for Diagnosis and Prognosis of Uveal Melanoma
por: Zhou, Wen-Da, et al.
Publicado: (2022)

MicroRNAs Role in Breast Cancer: Theranostic Application in Saudi Arabia
por: Alyami, Nouf M.
Publicado: (2021)

MicroRNAs as Theranostics Targets in Oral Carcinoma Stem Cells
por: Hsieh, Pei-Ling, et al.
Publicado: (2020)

MicroRNAs-Based Theranostics against Anesthetic-Induced Neurotoxicity
por: Minz, Roseleena, et al.
Publicado: (2023)

MicroRNAs in prostate cancer
por: Kim, Won Tae, et al.
Publicado: (2012)

microRNAs and prostate cancer
por: Shi, Xu-Bao, et al.
Publicado: (2008)

Circulating MicroRNAs as Biomarkers of Prostate Cancer: The State of Play
por: Sapre, Nikhil, et al.
Publicado: (2013)

Circulating microRNAs as potential new biomarkers for prostate cancer
por: Sita-Lumsden, A, et al.
Publicado: (2013)

Identification of MicroRNAs as Viable Aggressiveness Biomarkers for Prostate Cancer
por: Martínez-González, Luis Javier, et al.
Publicado: (2021)

MicroRNAs and lung cancer: Biology and applications in diagnosis and prognosis
por: Mallick, Reema, et al.
Publicado: (2010)

MicroRNAs as biomarkers for the progression and prognosis of colon carcinoma
por: Zhang, Hui, et al.
Publicado: (2018)

MicroRNAs as Biomarkers in Cancer
por: Sundarbose, Kamini, et al.
Publicado: (2013)

Identification of microRNAs associated with glioma diagnosis and prognosis
por: Ye, Xinyun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b2erqpo3h1pgvg4c145n04ki9h